Imiquimod 5% cream: a topical immune response modifier
- 1 May 2002
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 41 (s1) , 1-2
- https://doi.org/10.1111/j.1365-4632.2002.00016.x
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Imiquimod 5% Cream is a Safe and Effective Self-Applied Treatment for Anogenital Warts — Results of an Open-Label, Multicentre Phase IIIB TrialInternational Journal of STD & AIDS, 2001
- Review Article Imiquimod applied topically: a novel immune response modifier and new class of drugInternational Journal of Immunopharmacology, 1999
- Self-administered Topical 5% Imiquimod Cream for External Anogenital WartsArchives of Dermatology, 1998